_id

690dad0bccc777a4e85d09da

Ticker

ALDX

Name

Aldeyra The

Exchange

NASDAQ

Address

131 Hartwell Avenue, Lexington, MA, United States, 02421

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.aldeyra.com

Description

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platform, including ADX 248, ADX 743, ADX 631, ADX 246, and other product candidates in development for inflammatory and metabolic diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Last Close

4.59

Volume

1326674

Current Price

4.54

Change

-1.0893246187363796

Last Updated

2025-11-28T12:06:02.315Z

Image

data:image/webp;base64,UklGRvwGAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSGcFAAABuTJE9D9MXtv/nxtt+7/zPK993/d97b+dfd/3fd+vSea48Ppq4KOwyCWERWYDT2aZpYTILPo08FFY5BKGWWYDB9owHVhmkSuwwqJ0EBaZTQlW2HRgGY5LCIvMDjgwMht4McssJVhhkTsYZpld9GKR2XRgGUYREzABL8Q/EXzRK2X4kz/4Pfvv8wqv9iogv/U7z4Jmr/N6XEBtkv7KL6V/9KxewvHFa2Qg3m/8wq+Rc3Bv9QHv82bzAABYX/uub/k+F5D5dyqrH1PcRm/0bsN34TkKACT+iW8a/BRpIngHyZeKAAywwPo/MvueWYzsDd7LZNrPKD9nnMH7fq3LlBFKA6TarP1DOWlQrt/v7dxc8ABY2WuFfPImxg980SCWpx/xHqXlfs1XbTwEH7Z4i+zYjQGAC1XeeZsi/4aTcka2niayh4aWmgzNLD59xbKKWh805cls0N6w+kMeuQqNs9JfJ/38dDIAzP3pasYALDdKRdVVzSPqSIH7JQ/fEQ/Xq9UwGpycmvNcID1MNINlUb13OHMtHQ8TATB9PQBgtLfLo4EiKmtRLj8qCcaf9fyw+jjVX7SOXVWNU9jH0awbExbw0aolZpf39PhtE4SdVpcBp15bk3mOxi6RF59Qyx9Tx4fnX5aJZsZJi6GxUWAPbk6BM+cs4mosfPmT5mWnbn9dFAyTHNje3gokA5i21eA/SrXekd0v+Dwt0H1wn3IfV7AHm4HiUADpcSlgvTCzxXA7u0fAgM1pSWqcaWyUkbu+5stpObgYL/2OBacAcHyYiAXONg65S4eLopatT7OrPuzxhMlovOmN/MvauvSXt58z0KcqYAGVcuryaEzuDsJwIUelc80EoLrLdTSr5Ewu9b1uuRdXTJVUABjNLB7NskFXrcVAjzrsCAi55jQFRUujhA5F6+liSaT93xxylTaFZTfjdauMRNsDlh6s5lLXCB2E0+Tw0OtKaw6A4IZongk2lUM1nIOg7yHAOQ2DmwOPvja42JX7EoDhcedASuyA47gANhiz6XlAASDR5f7VjRcmIsAYPY9NKWCzFDSgFrXJOeQsBRBIOje+yD2pRZEFzDtHSJGibyypHIacTSq7KcqHMQDMH+vRw1Vb6oQQC+3YHBdZDNDcA+UdiDJ1habUItP+But9fPcZY9WUUItut99UUhINtqKNaVRajlm2J82oU9rvn6GLYfp0o1mS1FrR+GQ0kS1aMw+esryxCkcNH+vuQGhkdaS+i7PrJJzc3GlJx5k61mZHGnDSPjoAihZfUXAt+dJ32G7iniE+1vIJsD3CZeAezfzpaiJOxfL/j0w55TGBFSYd83gHdO9ouLNjQ390Lk0nn2w1gwaiKclGCkOL02gFrPfV6HnPEuvoelGk3VmcMpmPfGfCQHobRyb93kHqiEXHl6K08lgxZ9qAALvehiyuRTgJj9ur3XF6LZstX+cpsYD+bAaw8SieAmS8C2upjC7XZpASJgduBWA7Hggwp7VIS18dPfxvspqanH+5X2WgtucSIB13+1wAQMhvN/59y1L1spCtygWQjnssFOd3bX16Gb3sK+Pb00Tz71tZqEYyBQB78tQlaw5/u7265ff6XoZahhSAXc1OG1UGHp6ylZgshvY2PzzcOb645y1kAEg8Gm28MMPZymZ3oJEpRQUHz122ZwIvlQCO+eQgMN5cDK10M5vMCMerZUhiTRO8MNlTNLS3N70qi8SCs8AMQdimiYW/dXfjPKbRf1dyyvLxrWZnYSgTw+gb0AM07S27m+7WIACCokxUNLQ9Je7bZRgASN3uVotdI5DDwpFxbmU0yl2PUCpnFM1XlYeG1fIoCBWeOSOGkdr4h3sAVlA4IG4BAADwCACdASpAAEAAPq1InkmmJKMhM/TcAMAViWQAzsUXtvgvk5fgrh0AHtofAK4guyF5+psIj9u5kI/wPktQxUzHS25e2K6KOAPv92VrC2jUgAD++teAPsRMbjY8nBz1DgZrwzWbN36Ie3XV2aPc+Rs6mzbdNi9yFX7cJuKRsRcWmHL/g2/Oh/SUJKDbBXCupU8w0Xg3uM3KWDiglR6hsQCB3D92dfHLTulXvG6VRUJT0SlnzCKjDAw4Lhk4n9vvDHGuD+2b6Cdf4OASXxdkR0Q8HwcgqMxwNQAploWJEiUQ47L+swm8cLd51pQJ4djQrUlwVdNRYUZZ8zYB3zX5Dv5doF8ikpCqeRhh3MlyMFibzPcYhvbDn70gCLL7kad9e/x1xDT0o7ZbsAGZ9v2wwr6uK0n9WTUckKslxD9lYY+0ujvfjVe++FwDv9kEt8mh60dtUd0opOqRfVr8i5h/slmGF//w9ourT9zBfSIAAAA=

Ipo Date

2014-05-02T00:00:00.000Z

Market Cap

336309920

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.748

Sentiment Sources

2

Rating

4.7143

Target Price

9.6667

Strong Buy

5

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

63683

Gross Profit

-63683

Operating Expenses

8001132

Operating Income

-8001132

Interest Expense

475903

Pretax Income

-7688341

Net Income

-7688341

Eps

-0.12786868096366266

Dividends Per Share

-

Shares Outstanding

60162773

Income Tax Expense

-

EBITDA

-7148755

Operating Margin

-

Total Other Income Expense Net

312791

Cash

59340599

Short Term Investments

15956740

Receivables

-

Inventories

-

Total Current Assets

77460035

Property Plant Equipment

340977

Total Assets

77801012

Payables

13423

Short Term Debt

15471213

Long Term Debt

-

Total Liabilities

28556469

Equity

49244543

Depreciation

63683

Change In Working Capital

-1761320

Cash From Operations

-7021416

Capital Expenditures

4

Cash From Investing

25000000

Cash From Financing

120746

Net Change In Cash

18099330

PE

-

PB

5.54327205351464

ROE

-15.612574575014332

ROA

-9.882057832358274

FCF

-7021420

Fcf Percent

-

Piotroski FScore

1

Health Score

34

Deep Value Investing Score

3

Defensive Investing Score

6.5

Dividend Investing Score

1.5

Economic Moat Investing Score

3.3

Garp Investing Score

1.5

Growth Investing Score

0.5

Momentum Investing Score

3

Net Net Investing Score

2

Quality Investing Score

2

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

63683

Quarters > 0 > income Statement > gross Profit

-63683

Quarters > 0 > income Statement > operating Expenses

8001132

Quarters > 0 > income Statement > operating Income

-8001132

Quarters > 0 > income Statement > interest Expense

475903

Quarters > 0 > income Statement > pretax Income

-7688341

Quarters > 0 > income Statement > net Income

-7688341

Quarters > 0 > income Statement > eps

-0.12786868096366266

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

60126850

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-7148755

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

312791

Quarters > 0 > balance Sheet > cash

59340599

Quarters > 0 > balance Sheet > short Term Investments

15956740

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

77460035

Quarters > 0 > balance Sheet > property Plant Equipment

340977

Quarters > 0 > balance Sheet > total Assets

77801012

Quarters > 0 > balance Sheet > payables

13423

Quarters > 0 > balance Sheet > short Term Debt

15471213

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

28556469

Quarters > 0 > balance Sheet > equity

49244543

Quarters > 0 > cash Flow > net Income

-7688341

Quarters > 0 > cash Flow > depreciation

63683

Quarters > 0 > cash Flow > change In Working Capital

-1761320

Quarters > 0 > cash Flow > cash From Operations

-7021416

Quarters > 0 > cash Flow > capital Expenditures

4

Quarters > 0 > cash Flow > cash From Investing

25000000

Quarters > 0 > cash Flow > cash From Financing

120746

Quarters > 0 > cash Flow > net Change In Cash

18099330

Quarters > 0 > ratios > PE

-0.12786868096366266

Quarters > 0 > ratios > PB

5.54327205351464

Quarters > 0 > ratios > ROE

-15.612574575014332

Quarters > 0 > ratios > ROA

-9.882057832358274

Quarters > 0 > ratios > FCF

-7021420

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

34

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

62282

Quarters > 1 > income Statement > gross Profit

-62282

Quarters > 1 > income Statement > operating Expenses

10168732

Quarters > 1 > income Statement > operating Income

-10168732

Quarters > 1 > income Statement > interest Expense

470618

Quarters > 1 > income Statement > pretax Income

-9767312

Quarters > 1 > income Statement > net Income

-9767312

Quarters > 1 > income Statement > eps

-0.16266509763507792

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

60045530

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-9234412

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

401420

Quarters > 1 > balance Sheet > cash

41241269

Quarters > 1 > balance Sheet > short Term Investments

40678370

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

84558228

Quarters > 1 > balance Sheet > property Plant Equipment

404660

Quarters > 1 > balance Sheet > total Assets

84962888

Quarters > 1 > balance Sheet > payables

1455271

Quarters > 1 > balance Sheet > short Term Debt

15412448

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

29674746

Quarters > 1 > balance Sheet > equity

55288142

Quarters > 1 > cash Flow > net Income

-9767312

Quarters > 1 > cash Flow > depreciation

62282

Quarters > 1 > cash Flow > change In Working Capital

1332252

Quarters > 1 > cash Flow > cash From Operations

-8555222

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-554126

Quarters > 1 > cash Flow > cash From Financing

1002808997000

Quarters > 1 > cash Flow > net Change In Cash

-9109348

Quarters > 1 > ratios > PE

-0.16266509763507792

Quarters > 1 > ratios > PB

4.930654139182322

Quarters > 1 > ratios > ROE

-17.66619684922673

Quarters > 1 > ratios > ROA

-11.495974571862481

Quarters > 1 > ratios > FCF

-8555222

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

34

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

60912

Quarters > 2 > income Statement > gross Profit

-60912

Quarters > 2 > income Statement > operating Expenses

10427459

Quarters > 2 > income Statement > operating Income

-10427459

Quarters > 2 > income Statement > interest Expense

483529

Quarters > 2 > income Statement > pretax Income

-9929501

Quarters > 2 > income Statement > net Income

-9929501

Quarters > 2 > income Statement > eps

-0.16580394743433466

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

59887000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-9385060

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

497958

Quarters > 2 > balance Sheet > cash

50350617

Quarters > 2 > balance Sheet > short Term Investments

39707460

Quarters > 2 > balance Sheet > receivables

755545

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

92728775

Quarters > 2 > balance Sheet > property Plant Equipment

466942

Quarters > 2 > balance Sheet > total Assets

93195717

Quarters > 2 > balance Sheet > payables

346146

Quarters > 2 > balance Sheet > short Term Debt

255342

Quarters > 2 > balance Sheet > long Term Debt

15098529

Quarters > 2 > balance Sheet > total Liabilities

29597140

Quarters > 2 > balance Sheet > equity

63598577

Quarters > 2 > cash Flow > net Income

-9929501

Quarters > 2 > cash Flow > depreciation

60912

Quarters > 2 > cash Flow > change In Working Capital

-4750003

Quarters > 2 > cash Flow > cash From Operations

-12469699

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

7290414

Quarters > 2 > cash Flow > cash From Financing

1002810

Quarters > 2 > cash Flow > net Change In Cash

-4176475

Quarters > 2 > ratios > PE

-0.16580394743433466

Quarters > 2 > ratios > PB

4.27504816656511

Quarters > 2 > ratios > ROE

-15.612772279480405

Quarters > 2 > ratios > ROA

-10.654460655096413

Quarters > 2 > ratios > FCF

-12469699

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

37

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

244526

Quarters > 3 > income Statement > cost Of Revenue

64373

Quarters > 3 > income Statement > gross Profit

-64373

Quarters > 3 > income Statement > operating Expenses

16513411

Quarters > 3 > income Statement > operating Income

-16577784

Quarters > 3 > income Statement > interest Expense

470863

Quarters > 3 > income Statement > pretax Income

-15808767

Quarters > 3 > income Statement > net Income

-15808767

Quarters > 3 > income Statement > eps

-0.26576056148608895

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

59485000

Quarters > 3 > income Statement > income Tax Expense

3

Quarters > 3 > income Statement > EBITDA

-15273531

Quarters > 3 > income Statement > operating Margin

-6779.558819920991

Quarters > 3 > income Statement > total Other Income Expense Net

769017

Quarters > 3 > balance Sheet > cash

54527092

Quarters > 3 > balance Sheet > short Term Investments

46624180

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

104072478

Quarters > 3 > balance Sheet > property Plant Equipment

266955

Quarters > 3 > balance Sheet > total Assets

104606694

Quarters > 3 > balance Sheet > payables

180453

Quarters > 3 > balance Sheet > short Term Debt

303003

Quarters > 3 > balance Sheet > long Term Debt

15000000

Quarters > 3 > balance Sheet > total Liabilities

33601823

Quarters > 3 > balance Sheet > equity

71004871

Quarters > 3 > cash Flow > net Income

-15808767

Quarters > 3 > cash Flow > depreciation

64373

Quarters > 3 > cash Flow > change In Working Capital

2865532

Quarters > 3 > cash Flow > cash From Operations

-12036845

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-1563871

Quarters > 3 > cash Flow > cash From Financing

7779

Quarters > 3 > cash Flow > net Change In Cash

-13592937

Quarters > 3 > ratios > PE

-0.26576056148608895

Quarters > 3 > ratios > PB

3.8034277958198106

Quarters > 3 > ratios > ROE

-22.264341554820934

Quarters > 3 > ratios > ROA

-15.112576829930212

Quarters > 3 > ratios > FCF

-12036845

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-49.22521531452688

Quarters > 3 > health Score

30

Valuation > metrics > PE

-0.12786868096366266

Valuation > metrics > PB

5.54327205351464

Valuation > final Score

24.567279464853602

Valuation > verdict

84.8% Overvalued

Profitability > metrics > ROE

-15.612574575014332

Profitability > metrics > ROA

-9.925558386334322

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.5798910348299912

Risk > metrics > Interest Coverage

-16.812526922503114

Risk > final Score

-19

Risk > verdict

High

Liquidity > metrics > Current Ratio

5.002380101153169

Liquidity > metrics > Quick Ratio

5.002380101153169

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

30.69345860817678

Prev Valuations > 1

37.2495183343489

Prev Valuations > 2

41.9657220418019

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-38

Prev Risks > 1

-26

Prev Risks > 2

-81

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:13:01.911Z